C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway

European Journal of Endocrinology

Volumn 152, Issue 1, 2005, Pages 135-141

  Maestroni, Anna ^a   Ruggieri, Dora ^a   Dell'Antonio, Giacomo ^a   Luzi, Livio ^a   Zerbini, Gianpaolo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; PERTUSSIS TOXIN; RNA; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN ACTIVATED CALCIUM MOBILIZING RECEPTOR; VASOPRESSIN RECEPTOR;

ARTICLE; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESANGIUM CELL; MODULATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SKIN FIBROBLAST; TARGET CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; C-PEPTIDE; CELLS, CULTURED; CHROMONES; CULLIN PROTEINS; DIABETIC NEPHROPATHIES; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; GTP-BINDING PROTEINS; HUMANS; MORPHOLINES; PERTUSSIS TOXIN; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SKIN;

EID: 13244276334     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01823     Document Type: Article

References (41)

1. Steiner D, Cunningham D, Spigelman L & Aten B. Insulin biosynthesis: evidence for a precursor. Science 1967 157 697-700.
2. Rubenstein A, Clark J, Melani F & Steiner D. Secretion of proinsulin, C-peptide by pancreatic beta cells and its circulation in blood. Nature 1969 224 697-699.
3. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R & Jornvall H. Role of C-peptide in human physiology. American Journal of Physiology. Endocrinology and Metabolism 2000 278 E759-E768.
4. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, Nygren P, Stahl S, Ekberg K, Johansson B, Uhlen S, Uhlen M, Jornvall H & Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. PNAS 1999 96 13318-13323.
5. Johansson J, Ekberg K, Shafqat J, Henriksson M, Chibalin A, Wahren J & Jornvall H. Molecular effects of proinsulin C-peptide. Biochemical and Biophysical Research Communications 2002 295 1035-1040.
6. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, DiCera E & Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1998 277 563-566.
7. Sjoquist M, Huang W & Johansson B-L. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney International 1998 54 758-764.
8. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T & Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabetic Medicine 2000 17 181-189.
9. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P & Wahren J. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 2003 52 536-541.
10. Fioretto F, Steffes MW, Sutherland DER, Goetz FC & Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. New England Journal of Medicine 1998 339 69-75.
11. Fiorina P, Folli F, Zerbini G, Maffi P, Gremizzi C, Di Carlo V, Socci C, Bertuzzi F, Kashgarian M & Secchi A. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. Journal of the American Society of Nephrology 2003 14 2150-2158.
12. Luzi L. Pancreas transplantation and diabetic complications. New England Journal of Medicine 1998 339 115-117.
13. Shapiro AMJ. Islet transplants and impact on secondary diabetic complications: does C-peptide protect the kidney? Journal of the American Society of Nephrology 2003 14 2214-2216.
14. Zerbini G, Mangili R & Luzi L. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications. Diabetic Medicine 1999 16 1048.
15. Forst T, De La Tour DD, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J & Vague P. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na, K-ATPase activity in diabetes mellitus type I. Clinical Science 2000 98 283-290.
16. 2+ increases in human renal tubular cells. Cellular and Molecular Life Sciences 2002 59 1185-1189.
17. Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schafer D, Gopfert A, Pfutzner A, Beyer J & Forstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003 9 95-102.
18. Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T & Saito M. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 2003 46 1698-1705.
19. Blot-Chabaud M, Coutry N, Laplace M, Bonvalet J & Farman N. Role of protein phosphatase in the regulation of Na-K-ATPase by vasopressin in the cortical collecting duct. Journal of Membrane Biology 1996 153 233-239.
20. Feraille E, Mordasini D, Gonin S, Deschenes G, Vinciguerra M, Doucet A, Vandewalle A, Summa V, Verrey F & Martin PY. Mechanism of control of Na,K-ATPase in principal cells of the mammalian collecting duct. Annals of the New York Academy of Sciences 2003 986 570-578.
21. Martin PY, Bianchi M, Roger F, Niksic L & Feraille E. Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. American Journal of Physiology. Renal Physiology 2002 283 F559-F568.
22. Burnatowska-Hledin M, Spielman WS, Smith WL, Shi P, Meyer JM & Dewitt DL. Expression cloning of an AVP-activated calcium-mobilizing receptor from rabbit kidney medulla. American Journal of Physiology. Renal Physiology 1995 268 F1198-F1210.
23. Byrd PJ, Stankovic T, McConville CM, Smith AD, Cooper PR & Taylor AMR. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Research 1997 7 2-6.
24. Burnatowska-Hledin M, Lazdins IB, Listenberger L, Zhao P, Sharangpani A, Folta V & Card B. VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule. American Journal of Physiology. Renal Physiology 1999 276 F199-F209.
25. Burnatowska-Hledin M, Zhao P, Capps B, Poel A, Parmelee K, Mungall C, Sharangpani A & Listenberger L. VACM-1, a cullin gene family member, regulates cellular signaling. American Journal of Physiology. Cell Physiology 2000 279 C266-C273.
26. Isenovic ER, Jacobs DB, Kedees MH, Sha Q, Milivojevic N, Kawakami K, Gick G & Sowers JR. Angiotensin II regulation of the Na pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 2004 145 1151-1160.
27. Van Dort C, Zhao P, Parmelee K, Capps B, Poel A, Listenberger L, Kossoris J, Wasilevich B, Murrey D, Clare P & Burnatowska-Hledin M. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. American Journal of Physiology. Cell Physiology 2003 285 C1386-C1396.
28. Oyer PE, Cho S, Peterson JD & Steiner DF. Studies on human proinsulin. Isolation and amino acid sequence of the human pancreatic C-peptide. Journal of Biological Chemistry 1971 246 1375-1386.
29. Zerbini G, Mangili R, Gabellini D & Pozza G. Modes of operation of an electroneutral Na/Li counter transport in human skin fibroblasts. American Journal of Physiology. Cell Physiology 1997 272 C1373-C1379.
30. Lowry OH, Rosenbrough AL, Farr AL & Randall RJ. Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry 1951 193 265-275.
31. Sanchez-Margalet V, Goldfine ID, Vlahos CJ & Sung CK. Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochemical and Biophysical Research Communications 1994 204 446-452.
32. Sanchez-Margalet V. Stimulation of glycogen synthesis by insulin requires S6 kinase and phosphatidylinositol-3-kinase in HTC-IR cells. Journal of Cellular Physiology 2000 182 182-188.
33. Ruderman NB, Kapeller R, White MF & Cantley LC. Activation of phosphatidylinositol 3-kinase by insulin. PNAS 1990 87 1411-1415.
34. Becker EL, Kanaho Y & Kermode JC. Nature and functioning of the pertussis toxin-sensitive G protein of neutrophils. Biomedical Pharmacotherapy 1987 41 289-297.
35. Martinez-Olmedo MA & Garcia Sainz JA. Direct action of pertussis toxin in isolated hamster fat cells. European Journal of Pharmacology 1984 99 115-118.
36. Striker GE, Killen PD & Farin FM. Human glomerular cells in vitro: isolation and characterization. Transplantation Proceedings 1980 12 88-99.
37. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J & Pfutzner A. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1998 101 2036-2041.
38. Lidofsky SD, Xie MH, Sostman A, Scharschmidt BF & Fitz JG. Vasopressin increases cytosolic sodium concentration in hepatocytes and activates calcium influx through cation-selective channels. Journal of Biological Chemistry 1993 268 14632-14636.
39. Steffes MW, Osterby R, Chavers B & Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989 38 1077-1081.
40. Khorramizadeh MR, Tredget EE, Telasky C, Shen Q & Ghahary A. Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Molecular and Cellular Biochemistry 1999 194 99-108.
41. Steffes MW, Sibley S, Jackson M & Thomas W. Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care 2003 26 832-836.